Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
about
Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)Ganciclovir-mediated in vivo elimination of myeloid leukemic cells expressing the HSVtk gene induces HSVtk loss variants.Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives.Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells.Cytosine deaminase and thymidine kinase gene therapy in a Dunning rat prostate tumour model: absence of bystander effects and characterisation of 5-fluorocytosine metabolism with 19F-NMR spectroscopy.Baculovirus-transduced bone marrow mesenchymal stem cells for systemic cancer therapy.Cancer gene therapy with HSV-tk/GCV system depends on T-cell-mediated immune responses and causes apoptotic death of tumor cells in vivo.Dose of adenoviral vectors expressing interleukin-2 plays an important role in combined gene therapy with cytosine deaminase/5-fluorocytosine: preclinical consideration.Adenovirus-mediated tissue-specific cytosine deaminase gene therapy for human hepatocellular carcinoma with different AFP expression levels.Electroporation-mediated and EBV LMP1-regulated gene therapy in a syngenic mouse tumor model.Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector.
P2860
Q24792836-681DB60B-65B4-4E36-A9EB-C98D8B595BB6Q33178788-7736FD2D-501B-4650-99E3-DCA5B82AFAF6Q34176439-5D7A6386-DBD1-4308-BF9F-4F54C6FB391EQ38317782-9E5A79A1-1C1C-4EE9-A3EB-218252B5E799Q40691164-EF790A7A-5797-473F-8DAD-4314D59F9802Q43030477-A163D6BE-7F23-49CC-9348-49D9D8B5A20AQ43803202-B8BD5A48-B184-49A6-969A-D149FE85C693Q44038362-6E074849-A94A-4956-9F51-06414096C4DFQ44204484-68454636-F74B-427F-9AEC-100097197EC4Q44519499-E6CC3D25-AAAC-46A0-9C92-A137F1EF9DFDQ45867362-224599DB-AFD0-48BC-950C-258924185182
P2860
Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Killing Epstein-Barr virus-pos ...... implex virus thymidine kinase.
@en
type
label
Killing Epstein-Barr virus-pos ...... implex virus thymidine kinase.
@en
prefLabel
Killing Epstein-Barr virus-pos ...... implex virus thymidine kinase.
@en
P2093
P1433
P1476
Killing Epstein-Barr virus-pos ...... implex virus thymidine kinase.
@en
P2093
Comstock KE
Hoganson DK
Holley-Guthrie E
P304
P356
10.1089/HUM.1996.7.18-2235
P577
1996-12-01T00:00:00Z